Thalidomide use and outcomes in pediatric patients with Crohn disease refractory to infliximab and adalimumab.
Thalidomide use and outcomes in pediatric patients with Crohn disease refractory to infliximab and adalimumab. J Pediatr Gastroenterol Nutr. 2012 Jan; 54(1):28-33.